X4 Pharmaceuticals Company
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Industry:
Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Total Funding:
119499999
Investors Number:
12
Headquarters:
Cambridge, Massachusetts, United States
Technology:
Data-driven Technologies
Investor Type:
IPO
Last Funding Date:
2021
Founded Date:
2014
Employee Number:
51-100